Scarica l'app Stockscreener
0.717
5.70%
-0.0434
Precedente Chiudi:
$0.7603
Aprire:
$0.75
Volume 24 ore:
187.02K
Relative Volume:
0.75
Capitalizzazione di mercato:
$721.96K
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-82.88%
1M Prestazione:
-87.67%
6M Prestazione:
-98.61%
1 anno Prestazione:
-99.16%
Intervallo 1D:
$0.6879
$0.75
Intervallo di 1 settimana:
$0.64
$0.9122
Portata 52W:
$0.64
$101.62
Psyence Biomedical Ltd Stock (PBM) Company Profile
Nome
Psyence Biomedical Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta PBM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PBM
Psyence Biomedical Ltd
|
0.7063 | 777.16K | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
466.01 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
751.87 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
815.87 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
362.61 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.31 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Psyence Biomedical Ltd Borsa (PBM) Ultime notizie
Psyence BioMed Announces Adjournment of Annual and Special Shareholder Meeting on January 22, 2026 - The Manila Times
Too few shareholders: Psyence BioMed postpones meeting to Feb. 12 - Stock Titan
Psyence Biomedical Calls January 22, 2026 Shareholder Meeting to Vote on Financials, Board and Share Consolidation - TipRanks
Psyence Biomedical sets Jan. 20 as effective date for reverse stock split - MSN
Psyence Biomedical postpones planned reverse stock split By Investing.com - Investing.com Nigeria
Psyence Biomedical announces postponement of reverse stock split effective date - TipRanks
Psyence Biomedical postpones planned reverse stock split - Investing.com
Psyence Biomedical Ltd. Announces Postponement of Reverse Stock Split Effective Date - Quiver Quantitative
Psyence BioMed Announces Postponement of Previously Announced Reverse Stock Split Effective Date - GlobeNewswire
Reverse stock split on hold: Psyence BioMed keeps PBM trading - Stock Titan
Why Psyence Biomedical Ltd. stock could benefit from AI revolutionConsumer Goods Stocks & Free Powerful Profit Generation - bollywoodhelpline.com
Psyence BioMed Sets January 20, 2026 Start Date for 1-for-6.25 Reverse Stock Split - TipRanks
Day Trade: Is RLAY forming a bullish divergenceJuly 2025 Snapshot & Weekly High Return Stock Forecasts - baoquankhu1.vn
Can Psyence Biomedical Ltd. outperform in the next rally2025 Volatility Report & Weekly Watchlist for Consistent Profits - bollywoodhelpline.com
Entry Recap: Will Psyence Biomedical Ltd benefit from rate cutsWeekly Loss Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Aug Technicals: Is Psyence Biomedical Ltd a top pick in the sectorJuly 2025 Reactions & Smart Money Movement Tracker - baoquankhu1.vn
Quarterly Recap: Whats the beta of Psyence Biomedical Ltd stockGap Down & Daily Technical Forecast Reports - baoquankhu1.vn
Psyence Biomedical Shares Set to Reverse Split on Tuesday, January 20th (NASDAQ:PBM) - Defense World
Breakout Move: Can LSI Industries Inc. benefit from deglobalizationPortfolio Gains Summary & Safe Capital Growth Tips - baoquankhu1.vn
Psyence Biomedical (PBM) Announces 1-for-6.25 Reverse Stock Split Effective January 20, 2026 - Intellectia AI
Psyence Biomedical announces 1-for-6.25 share consolidation By Investing.com - Investing.com Nigeria
1-for-6.25 split leaves Psyence BioMed with 1,022,177 shares outstanding - Stock Titan
Psyence Biomedical Ltd. Announces 1-for-6.25 Share Consolidation Effective January 20, 2026 - Quiver Quantitative
Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split - Chartmill
Aug Catalysts: Can Psyence Biomedical Ltd Equity Warrant outperform in the next rally2025 Support & Resistance & Precise Swing Trade Alerts - baoquankhu1.vn
Psyence Biomedical Board Backs 2026 Strategy and Potential Share Buyback Program - TipRanks
Psyence Biomedical Ltd. (NASDAQ:PBM) Short Interest Down 63.6% in December - Defense World
Psyence BioMed Approves 2026 Financial Strategy, Board Authorizes Share Buyback on Value Opportunity - The Manila Times
Psyence Biomedical Ltd. announces an Equity Buyback. - marketscreener.com
How Psyence Biomedical Ltd. stock performs in weak economyJuly 2025 Selloffs & Risk Adjusted Buy and Sell Alerts - Улправда
What is the fair value of Psyence Biomedical Ltd. stock nowFit and Size Notes & lightweight options for faster days - ulpravda.ru
Comparing Compugen (NASDAQ:CGEN) & Psyence Biomedical (NASDAQ:PBM) - Defense World
Is Psyence Biomedical Ltd. stock attractive for hedge fundsWeekly Trade Report & Expert Curated Trade Setup Alerts - ulpravda.ru
Surprises Report: Will Psyence Biomedical Ltd. Equity Warrant stock gain from strong economyJuly 2025 Breakouts & Daily Price Action Insights - Улправда
Will Psyence Biomedical Ltd. stock benefit from infrastructure spendingJuly 2025 PostEarnings & Reliable Breakout Forecasts - Улправда
What valuation multiples suggest for Psyence Biomedical Ltd. Equity Warrant stockQuarterly Investment Review & Reliable Intraday Trade Alerts - ulpravda.ru
How currency fluctuations impact Psyence Biomedical Ltd. Equity Warrant stock2025 Trading Volume Trends & Low Volatility Stock Recommendations - ulpravda.ru
Can Psyence Biomedical Ltd. stock rebound after recent weaknessWeekly Trade Report & Reliable Intraday Trade Alerts - Улправда
Will Psyence Biomedical Ltd. Equity Warrant stock deliver consistent dividendsMarket Activity Recap & Weekly Breakout Watchlists - Улправда
Why Psyence Biomedical Ltd. Equity Warrant stock appeals to analystsWeekly Stock Analysis & Expert Verified Stock Movement Alerts - Улправда
How Psyence Biomedical Ltd. stock reacts to oil pricesWeekly Earnings Recap & Technical Confirmation Trade Alerts - Улправда
Psyence Biomedical Ltd.Ordinary Shares (NQ: PBM - FinancialContent
Psyence Biomedical announces milestone in natural ibogaine HCl production - TipRanks
Psyence Biomedical Ltd. Announces Board Changes - marketscreener.com
Psyence BioMed Achieves Milestone in Natural Ibogaine HCl Production and Strengthens Balance Sheet With No Debt and $12m Cash - The Manila Times
Published on: 2026-01-04 19:06:08 - earlytimes.in
Investment Recap: Why Psyence Biomedical Ltd Equity Warrant stock appeals to analystsCPI Data & Real-Time Market Sentiment Alerts - Bộ Nội Vụ
Gainers Report: Why Psyence Biomedical Ltd stock could benefit from AI revolutionSell Signal & Real-Time Chart Pattern Alerts - moha.gov.vn
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing - TMX Newsfile
Psyence Biomedical (NASDAQ:PBM) Trading Down 6.1% – Here’s Why - Defense World
Psyence Biomedical Ltd Azioni (PBM) Dati Finanziari
Non sono disponibili dati finanziari per Psyence Biomedical Ltd (PBM). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
3.27%
2.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):